With the news that Sarah Ferguson has been diagnosed with an aggressive form of skin cancer, after previously battling with breast cancer, the condition has been brought to the forefront of the public’s mind once again.
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine to produce a CAR T cell therapy for multiple myeloma, the second most common malignancy among blood cancers.